[KTTA] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[KTTA] Pasithea Therapeutics Corp.
Announcement Date
28-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -39.72%
YoY- -29.37%
Quarter Report
KTTA's Result
KTTA's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 0 0 0 976 0 0 0 -
PBT -2,999,834 -3,866 -3,861 -5,031 -3,613 -3,598 -3,266 9232.33%
Tax 0 0 0 17 -162 -65 271,869 -
NP -2,999,834 -3,866 -3,861 -5,048 -3,613 -3,763 -275,135 389.56%
Tax Rate - - - - - - - -
Total Cost 2,999,834 3,866 3,861 6,024 3,613 3,763 275,135 389.56%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 0.00 0.00 0.00 -517.07 0.00 0.00 0.00 -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -2,873.01 -3.71 -3.70 -4.85 -2.87 -2.88 -211.05 467.41%
EPS Diluted -2,873.01 -3.71 -3.70 -4.85 -2.87 -2.88 -211.05 467.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.